Navigation Links
China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results
Date:6/1/2011

 notes

(24,064)(1,570)(240)Adjusted EBITDA (4)

99,591140,24421,417For the Year EndedMarch 31, 2010March 31, 2011RMBRMBUS$As adjusted (1)(in thousands)Net income (loss)

(69,582)82,61912,617Adjustments:Interest income

(13,456)(20,882)(3,189)Interest expense – convertible notes

141,123131,91820,145Interest expense – amortization of convertible 
notes issuance costs

17,40216,0092,445Interest expense – amortization of share 
lending costs

10,9129,7311,486Income tax expense

63,55693,82814,329EBIT (2)

149,955313,22347,833Adjustments:Depreciation

22,13721,9533,352Amortization

199,115196,03029,936EBITDA (3)

371,207531,20681,121EBITDA (3)

371,207531,20681,121Adjustments:Stock compensation expense

40,43737,1545,674Gain on repurchase of convertible notes(24,064)(80,342)(12,269)High yield note offering expenses

-5,236800Adjusted EBITDA (4)

387,580493,25475,326Notes:(1) As a result of the adoption of new authoritative guidance governing the accounting for own-share lending arrangements in contemplation of convertible debt issuance or other financing effective on April 1, 2010, the Company adjusted relevant numbers in the unaudited condensed consolidated statements of income for the three months and the year ended March 31, 2010 retrospectively in accordance with GAAP.(2) EBIT represents net income reported in accordance with GAAP, excluding the effects of interest income, interest expense and income tax expense.(3) EBITDA represents net income repor
'/>"/>

SOURCE China Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... CHENGDU, China , July 30, 2015 ... "Company"), a pharmaceutical company that specializes in the patented ... active pharmaceutical ingredients (API), provided updates regarding the notice ... MKT LLC (the "Exchange") indicating that the Company was ... set forth in Sections 134 and 1101 of the ...
(Date:7/30/2015)... , July 30, 2015 Eisai Inc. announced ... the United States , European Union and ... and MHLW, respectively) for eribulin, for the treatment of ... received prior chemotherapy for advanced or metastatic disease. ... from a pivotal global Phase 3 clinical trial (Study ...
(Date:7/30/2015)... , July 30, 2015 ... latest report titled, "Continuous Glucose Monitoring Systems Market: Global ... to the report, the global continuous glucose monitoring systems ... and is expected to reach US$ 788.4 Mn by ... period, 2015 to 2020. Global continuous glucose ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
... Reports Significantly More Patients Treated,with Taxotere(R)-Based ... CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- ... maintained long-term efficacy as a treatment ... to the three-year updated results of ...
... - Schering-Plough Corp. announced results,from a Phase ... (pegylated liposomal doxorubicin hydrochloride),significantly prolonged time to ... with infrequent and manageable clinical,toxicity after first-line ... 43rd Annual Meeting of the American Society ...
Cached Medicine Technology:Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 2Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 3Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 4Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 2Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 3Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 4Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 5
(Date:7/31/2015)... CA (PRWEB) , ... July 31, 2015 , ... ... by High Times magazine. What are the STASH awards? The Significant Technological ... made by the cannabis-cultivation community as well as tried-and-true products that have stood ...
(Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of Nursing, ... on the Future of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. ... this meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit ...
(Date:7/31/2015)... ... July 31, 2015 , ... Precision Aesthetics is New York’s only Thermage ... also the first provider of Exilis non-surgical fat reduction in New York. Due ... attracted a large International clientele. Many patients travel to New York to get ...
(Date:7/31/2015)... ... 2015 , ... The 2nd annual Ride to Fight On will start and ... 2015. The Ride to Fight On is a cycling fundraiser that benefits the West ... Clinic and The University of Tennessee Health Science Center. A health and wellness festival ...
(Date:7/31/2015)... ... July 31, 2015 , ... Jacksonville-based drug ... new True North Conference Center. The medical community, social workers, law enforcement, and ... be more aligned in the effort to better understand and combat sex trafficking. ...
Breaking Medicine News(10 mins):Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3
... ... global leader in strategic consulting, was named a 2009 “Purveyor of the Year” by ... has provided Outback Steakhouse with custom, strategic learning solutions to help cascade strategies throughout ... ...
... Innovative ... around the globe. , ... (PRWEB) April 9, 2010 -- CareCloud today announced that it has been selected ... innovative solutions are “disrupting the established enterprise and pioneering cloud computing and SaaS.” The ...
... Gastrointestinal (GI) chronic perforations require closure and control ... stents or plastic stents are an effective ... have many drawbacks. Using the newly designed ... bleeding to close two chronic inveterate external gastric ...
... Women should get retested whenever they change sexual partners, ... -- Once-a-year screening for chlamydia isn,t likely to protect ... A new study has found that most cases of ... chlamydia infection when they were screened, which suggests they ...
... ... emergency medical cache of disposable medical supplies, ready for quick use by patients and ... (PRWEB) ... of preparing for the possibility of a large scale health emergencies. Healthcare organizations need ...
... ... with the apps Rx for a busy life. ,Life gets hectic. Heck, ... mobile applications for iPhone, iPod touch, and the new IPad is on ... your busy life less stressful, less complicated and yes… more productive! Rooted ...
Cached Medicine News:Health News:Root Learning Named “Purveyor of the Year” For Strategic Partnership with Outback Steakhouse 2Health News:CareCloud Ranked Among Top SaaS Companies 2Health News:Yearly Chlamydia Screening May Be Ineffective for Some 2Health News:Provide Medical Surge Care with MasCache by DQE 2Health News:Dr. Appz Launches Comprehensive Productivity App for iPhone 2
Conforms to the convexity of the lens providing easier access to anterior capsule. Reduces pontential of corneal touch. 23G x 5/8in (.60 x 16mm)...
... LASIK surgery and other types of ... corneal interface and/or stromal bed. Flattened ... flap and helps elevate the flap ... x 7/8in (.40 x 22mm) Formed ...
... Unique product designed for LASIK ... surgery. Designed to irrigate the corneal ... provides easy insertion under the flap ... Multiple ports provide multi-directional irrigation. Two ...
... for LASIK surgery and other types of ... interface and/or stromal bed. Flattened tip provides ... elevate the flap edge. Multiple ports provide ... 22mm) Formed 7mm from end. Two .15mm ...
Medicine Products: